Analysis of HER2-low breast cancer in Aotearoa New Zealand: a nationwide retrospective cohort study

Annette Lasham, Reenadevi Ramsaroop, Abbey Wrigley, Nicholas Knowlton
doi: https://doi.org/10.1101/2024.07.10.24310238

Article Information

doi 
https://doi.org/10.1101/2024.07.10.24310238
History 
  • July 11, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Annette Lasham1,*,
  2. Reenadevi Ramsaroop2,
  3. Abbey Wrigley3 and
  4. Nicholas Knowlton4,5
  1. 1Department of Molecular Medicine and Pathology, University of Auckland
  2. 2Waitematā Hospital, Health NZ
  3. 3Canopy Cancer Care
  4. 4Department of Obstetrics and Gynaecology and Reproductive Sciences, University of Auckland
  5. 5School of Mathematical and Computational Sciences, Massey University, Albany
  1. ↵*Corresponding author
    Dr Annette Lasham, Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland 1142., Tel: +64 9 923 5044, Email: a.lasham{at}auckland.ac.nz
Back to top
Posted July 11, 2024.
Download PDF
Data/Code
Email
Analysis of HER2-low breast cancer in Aotearoa New Zealand: a nationwide retrospective cohort study
Annette Lasham, Reenadevi Ramsaroop, Abbey Wrigley, Nicholas Knowlton
medRxiv 2024.07.10.24310238; doi: https://doi.org/10.1101/2024.07.10.24310238
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area